Patents by Inventor Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED HETEROARYL ALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
    Publication number: 20130190316
    Abstract: Provided are substituted heteroaryl aldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 25, 2013
    Applicants: Global Blood Therapeutics, Inc., The Regents of the University of California, Cytokinetics, Inc.
    Inventors: Global Blood Therapeutics, Inc., Cytokinetics, Inc., The Regents of the University of California
  • SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
    Publication number: 20130190315
    Abstract: Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 25, 2013
    Applicants: Global Blood Therapeutics, Inc., The Regents of the University of California, Cytokinetics, Inc.
    Inventors: Global Blood Therapeutics, Inc., Cytokinetics, Inc., The Regents of the University of California